<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0009">
 <label>9</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Foster</surname>
    <given-names>PA</given-names>
   </name>, 
   <name name-style="western">
    <surname>Chander</surname>
    <given-names>SK</given-names>
   </name>, 
   <name name-style="western">
    <surname>Newman</surname>
    <given-names>SP</given-names>
   </name>, 
   <etal>et al.</etal>
  </person-group>
  <article-title>A new therapeutic strategy against hormone-dependent breast cancer: the preclinical development of a dual aromatase and sulfatase inhibitor</article-title>. 
  <source>Clin Cancer Res</source>
  <year>2008</year>;
  <volume>14</volume>:
  <fpage>6469</fpage>–
  <lpage>77</lpage>.
  <pub-id pub-id-type="pmid">18927286</pub-id>
 </mixed-citation>
</ref>
